Pesquisas alternativas:
disease liver » disease like (Expandir a Pesquisa), disease linked (Expandir a Pesquisa), disease living (Expandir a Pesquisa)
does develop » boys develop (Expandir a Pesquisa), loss develop (Expandir a Pesquisa), does developing (Expandir a Pesquisa)
develop them » develop type (Expandir a Pesquisa)
drug disease » during disease (Expandir a Pesquisa), drug release (Expandir a Pesquisa)
liver thle2 » liver three (Expandir a Pesquisa)
drug noise » drug naive (Expandir a Pesquisa), drug nurse (Expandir a Pesquisa), during noise (Expandir a Pesquisa)
level ther » level theory (Expandir a Pesquisa), level rather (Expandir a Pesquisa), levels other (Expandir a Pesquisa)
drug does » drug doses (Expandir a Pesquisa), drugs does (Expandir a Pesquisa), drug dose (Expandir a Pesquisa)
disease liver » disease like (Expandir a Pesquisa), disease linked (Expandir a Pesquisa), disease living (Expandir a Pesquisa)
does develop » boys develop (Expandir a Pesquisa), loss develop (Expandir a Pesquisa), does developing (Expandir a Pesquisa)
develop them » develop type (Expandir a Pesquisa)
drug disease » during disease (Expandir a Pesquisa), drug release (Expandir a Pesquisa)
liver thle2 » liver three (Expandir a Pesquisa)
drug noise » drug naive (Expandir a Pesquisa), drug nurse (Expandir a Pesquisa), during noise (Expandir a Pesquisa)
level ther » level theory (Expandir a Pesquisa), level rather (Expandir a Pesquisa), levels other (Expandir a Pesquisa)
drug does » drug doses (Expandir a Pesquisa), drugs does (Expandir a Pesquisa), drug dose (Expandir a Pesquisa)
1
Por Zhang, Meijuan, Wang, Haiying, Zhao, Jinbing, Chen, Cong, Leak, Rehana K., Xu, Yun, Vosler, Peter, Gao, Yanqin, Zhang, Feng
Publicado em 2013
“... to induce therapeutic hypothermia have been established; however, most of them are not clinically feasible...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Artigo
2
“... them into drug-design and -discovery workflows while trying to answer a critical question: are QM-based...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Wesnes, Keith A.
Publicado em 2000
“... of the core deficits of Alzheimer's disease can be used to screen potential antidernentia drugs. Ultimately...”Publicado em 2000
Obter o texto integral
Obter o texto integral
Artigo
4
Por A. E. Karateyev
Publicado em 2013-12-01
Assuntos:
“...nonsteroidal anti-inflammatory drugs...”Publicado em 2013-12-01
Obter o texto integral
Artigo
5
“... approach “Design of Experiments (DoE)” as applicable to formulation development of microparticles...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Takenaka, Yukinori, Fukumori, Tomoharu, Yoshii, Tadashi, Oka, Natsuo, Inohara, Hidenori, Kim, Hyeong-Reh Choi, Bresalier, Robert S., Raz, Avraham
Publicado em 2004
Assuntos:
“...Cell Growth and Development...”Publicado em 2004
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Yildirim, Oktay, Gottwald, Matthias, Schüler, Peter, Michel, Martin C.
Publicado no Front Pharmacol (2016)
“...Drug development faces the double challenge of increasing costs and increasing pressure on pricing...”Publicado no Front Pharmacol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Mingote, Susana, Masson, Justine, Gellman, Celia, Thomsen, Gretchen M., Lin, Chyuan-Sheng, Merker, Robert J., Gaisler-Salomon, Inna, Wang, Yvonne, Ernst, Rachel, Hen, René, Rayport, Stephen
Publicado no Front Syst Neurosci (2016)
“...Genetic pharmacotherapy is an early drug development strategy for the identification of novel CNS...”Publicado no Front Syst Neurosci (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Song, Chull S., Moses, Harold L., Rosenthal, Alan S., Gelb, Nancy A., Kappas, Attallah
Publicado em 1971
“.... The ultrastructural changes which accompany the induction of ALAS by drugs and chemicals in adult liver also fail...”Publicado em 1971
Obter o texto integral
Obter o texto integral
Artigo
10
“... to an antibiotic are also discussed. Lastly, the methods that have been developed for the identification...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Phansalkar, Shobha, Desai, Amrita A, Bell, Douglas, Yoshida, Eileen, Doole, John, Czochanski, Melissa, Middleton, Blackford, Bates, David W
Publicado em 2012
“...OBJECTIVE: To develop a set of high-severity, clinically significant drug–drug interactions (DDIs...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Hoffman, G S
Publicado em 2011
“... the disease, plus vulnerabilities of the patient that prepare them to develop an illness phenotype. Improved...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Blaine Stothard
Publicado em 2021-11-01
Assuntos:
“...drug policy and control...”Publicado em 2021-11-01
Obter o texto integral
Artigo
14
Por Csete, Joanne, Kamarulzaman, Adeeba, Kazatchkine, Michel, Altice, Frederick, Balicki, Marek, Buxton, Julia, Cepeda, Javier, Comfort, Megan, Goosby, Eric, Goulão, João, Hart, Carl, Horton, Richard, Kerr, Thomas, Lajous, Alejandro Madrazo, Lewis, Stephen, Martin, Natasha, Mejía, Daniel, Mathiesson, David, Obot, Isidore, Ogunrombi, Adeolu, Sherman, Susan, Stone, Jack, Vallath, Nandini, Vickerman, Peter, Zábranský, Tomáš, Beyrer, Chris
Publicado no Lancet (2016)
“... their health, human rights, and development impact. The Johns Hopkins – Lancet Commission on Drug Policy...”Publicado no Lancet (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Krzysztof Siemianowicz, Wirginia Likus, Mariola Dorecka, Renata Wilk, Włodzimierz Dziubdziela, Jarosław Markowski
Publicado em 2018-01-01
“... technologies for provision of pharmaceutical forms of them, including drug nanocarriers, are currently underway...”Publicado em 2018-01-01
Obter o texto integral
Artigo
16
“...CML is a clonal multistep myeloproliferative disease originating from and ultimately sustained by a...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
“... nature of the disease process makes BPD a challenging condition to treat. While multiple pharmacologic...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por López-Riera, Mireia, Conde, Isabel, Tolosa, Laia, Zaragoza, Ángela, Castell, José V., Gómez-Lechón, María J., Jover, Ramiro
Publicado no Front Pharmacol (2017)
“... in miRNA levels were measured by microarray and qRT-PCR. Drug-induced fat accumulation in HepG2...”Publicado no Front Pharmacol (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por John Leonardo Torres-Castiblanco, Jorge Alberto Carrillo, Daniel Hincapié-Urrego, Adriana Rojas-Villarraga
Publicado no Biomédica (2018)
“... of rheumatoid arthritis, among them, the first line of disease-modifying antirheumatic drugs (DMARD), and novel...”Publicado no Biomédica (2018)
Obter o texto integral
Artigo
20
Por Parolin, Micol, Simonelli, Alessandra, Mapelli, Daniela, Sacco, Marianna, Cristofalo, Patrizia
Publicado no Front Psychol (2016)
“...Parental substance use is a major risk factor for child development, heightening the risk of drug...”Publicado no Front Psychol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo